Description
Nanox Bio Retatrutide is a premium peptide research formulation containing Retatrutide, a novel investigational peptide extensively studied for its activity as a triple receptor agonist targeting the Glucagon-Like Peptide-1 (GLP-1) Receptor, Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor, and Glucagon Receptor (GCGR). Developed exclusively for laboratory research, Retatrutide has become an important peptide in studies involving metabolic physiology, energy homeostasis, endocrine signaling, glucose metabolism, and molecular endocrinology.
By simultaneously activating GLP-1, GIP, and glucagon receptors, Retatrutide enables researchers to investigate multi-receptor peptide pharmacology, intracellular signaling, metabolic regulation, energy expenditure, nutrient sensing, and endocrine communication. Its unique triple-agonist mechanism has established Retatrutide as one of the most advanced investigational peptides for metabolic and endocrine research.
Each package contains 10 sterile vials, with 10 mg of Retatrutide per vial, manufactured by Nanox Bio under stringent pharmaceutical-quality standards. Every batch undergoes comprehensive quality testing to ensure exceptional purity, peptide integrity, and dependable laboratory performance.
Key Features
- Premium Retatrutide peptide research formulation
- 10 mg per vial
- 10 sterile vials per package
- Triple receptor agonist targeting GLP-1, GIP, and Glucagon receptors
- High-purity laboratory-grade peptide
- Extensively researched in metabolic physiology and endocrine biology
- Suitable for investigations involving GLP-1 receptor signaling, GIP receptor biology, glucagon receptor pharmacology, glucose metabolism, energy homeostasis, peptide pharmacology, intracellular signaling, and molecular endocrinology
- Manufactured under rigorous pharmaceutical-quality standards
- Intended exclusively for laboratory and scientific research applications
How It Works
Retatrutide simultaneously activates the GLP-1 receptor (GLP-1R), GIP receptor (GIPR), and Glucagon receptor (GCGR), allowing researchers to investigate coordinated endocrine signaling across multiple metabolic pathways. This multi-receptor activity provides a valuable platform for studying energy balance, nutrient metabolism, receptor pharmacology, cellular communication, and peptide-mediated signaling.
In laboratory studies, Retatrutide is extensively utilized to examine glucose metabolism, insulin signaling, glucagon physiology, intracellular signaling pathways, receptor-ligand interactions, metabolic regulation, and endocrine communication. Its triple-agonist profile continues to make it a leading investigational peptide for advanced metabolic and peptide research.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredient (Per Vial):
- Retatrutide – 10 mg
Packaging:
- 10 Sterile Vials
Reviews
There are no reviews yet.